Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

NCT02079740 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

96

Enrollment

NIH

Sponsor class

Conditions

Metastatic Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Navitoclax
PROCEDURE: Positron Emission Tomography
DRUG: Trametinib

Sponsor

National Cancer Institute (NCI)